ILA — Island Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$96.17m
- AU$83.30m
- AU$0.28m
Australia's Island Pharmaceuticals hits 3-week high on US patent grant
Brief: Island Pharmaceuticals Acquires Grant Research Support
Brief: Island Pharmaceuticals Says Got Clearance From U.S. FDA For Its ISLA-101 Investigational NDA
Brief: Island Pharmaceuticals Says Island Submits Responses To FDA Questions For Isla-101
Brief: Island Pharmaceuticals Updates On Feedback Following FDA Review Of An IND
Brief: Island Pharmaceuticals Got Feedback Following U.S. FDA Review Of Ind Application
Brief: Island Pharmaceuticals Says IND To U.S. FDA For Phase 2A Peach Clinical Trial
Brief: Island Pharmaceuticals Receives IRB Approval For ISLA-101 Phase 2A Peach 1 Clinical Trial
Australia's Island Pharma hits 6-1/2-month high on Canadian patent
Australia's Island Pharmaceuticals hits record low on clinical material making delay
Australia Stock Exchange release from ISLAND PHARMACEU : Release of Securities from Escrow
Australia Stock Exchange release from ISLAND PHARMACEU : Appendix 4D & Half-Year Financial Statements
Australia Stock Exchange release from ISLAND PHARMACEU : PRE_NR Ends: 17:03:52
Australia Stock Exchange release from ISLAND PHA : Application for quotation of securities - ILA
Australia Stock Exchange release from ISLAND PHA : Updated Investor Presentation & Webinar Invitation
Australia Stock Exchange release from ISLAND PHA : Change in substantial holding
Australia Stock Exchange release from ISLAND PHA : Release of Securities from Escrow
Australia Stock Exchange release from ISLAND PHA : Quarterly Activity Report & Appendix 4C
Australia Stock Exchange release from ISLAND PHA : PRE_NR Ends: 16:46:53